NFL ordered to dump ‘race-based’ formula for determining concussion damage, opening door for millions in settlements for retired Black players

Credit: Asha Wire
Credit: Asha Wire

The federal judge overseeing the N.F.L. concussion settlement formally removed the use of a race-based method to evaluate dementia tests of Black former players, paving the way for thousands of players to file claims worth potentially hundreds of thousands of dollars.

The order issued on [March 4] by United States District Judge Anita B. Brody, who has overseen the case since it began in 2012, ends a contentious, 18-month fight that began after two former players sued the N.F.L. for discrimination.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The administrator of the settlement now must rescore dementia tests taken by several thousand Black former players who had submitted claims. They will be notified if their new scores allow them to file a claim for a financial payout. If they meet scoring thresholds and have a qualifying diagnosis, their claims are still subject to the N.F.L.’s appeal and their cases can be audited.

“I think it is a step in the right direction,” said [former NFL player Najeh] Davenport, who with [Kevin] Henry filed the discrimination suit in 2020. “With race relations in America, we have a long way to go. I was glad to contribute. I hope other organizations take heed and do the right thing.”

This is an excerpt. Read the original post here.

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.